- Research works
- 8 ▼ 24% vs 2013–17
- Citations
- 67 8.1 per fractional work
- Top-10% rate
- 12.6% record average 16.5%
- Open access
- 62% world 28%
Not ranked overall: Inceptus (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Inceptus (United States) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, Nail Diseases and Treatments and Bladder and Urothelial Cancer Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 0 works
- 2 Epigenetics and DNA Methylation Molecular Biology 0 works
- 3 Nail Diseases and Treatments Epidemiology 0 works
- 4 Bladder and Urothelial Cancer Treatments Surgery 0 works
- 5 Acute Myeloid Leukemia Research Hematology 0 works
- 6 Plant Pathogens and Fungal Diseases Cell Biology 0 works
- 7 Fungal Infections and Studies Epidemiology 0 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 9 Gastrointestinal Tumor Research and Treatment Gastroenterology 0 works
- 10 Urinary and Genital Oncology Studies Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Inceptus (United States)'s research output changed?
Output in 2018–2022 was 24% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Aliso Viejo
- Soka University of America
- American Association of Critical-Care Nurses
- NeoGenomics (United States)
- Ambry Genetics (United States)
- Microsemi (United States)
- Avanir Pharmaceuticals (United States)
- NVision Eye Centers (United States)
- RxSight (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.